Earnings call Myer Group reported FY25 revenue of $3.7B, up 0.5% on a pro forma basis, with online sales up 15%. However, EBIT fell 13.8% and underlying EBIT dropped 30% due to macro softness and ...
This decline marks Tesla's steepest decline in years while rivals gain ground. Is this a temporary bump in the road or a bigger trend to be worried about? Sentencing underway for Sean 'Diddy' Combs ...
Tesla sales surged in Turkey this August, and many are wondering what caused the sudden boom. According to Electrek, Tesla delivered 8,730 Model Y vehicles in the country last month, matching its ...
Rockets president of business operations Gretchen Sheirr said Thursday that the franchise experienced a 25 percent rise in season-ticket sales compared to last year ahead of the upcoming season.
The iPhone 17 Pro has landed with a better zoom, more performance, and a new aluminum unibody frame. Here's how it compares against its predecessor, the iPhone 16 Pro. For 2025, the iPhone 17 Pro ...
Mama's Creations(NASDAQ:MAMA) reported second quarter fiscal 2026 results on September 8, 2025, delivering 24% year-over-year revenue growth to $35.2 million and announcing the $17.5 million all-cash ...
USDA’s September 2025 net farm income forecast, released Sept. 3, projects net farm income will rise sharply from 2024. While stronger performance in some sectors is a factor in the increase, much of ...
HOLLYWOOD, FL and MIAMI, FL / ACCESS Newswire / August 25, 2025 / HEICO CORPORATION (NYSE:HEI.A)(NYSE:HEI) today reported an increase in net income of 30% to a record $177.3 million, or $1.26 per ...
Tennis pro Sachia Vickery isn’t exactly a household name in the sport. The 30-year-old Florida native is ranked No. 559 in the world as she looks to qualify for the 2025 U.S. Open. She’s earned just ...
Last weekend, Ryan Weitz logged into what she thought was her personal TikTok account and added her own name—Ryan—as its display name. Then, she realized the account actually belonged to Sweet Loren’s ...
Emmaus Life Sciences is a specialty drug company targeting rare conditions, most notably sickle cell disease. Its flagship product, Endari®, is an oral pharmaceutical formulation of L-glutamine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback